Edit Entry | Edit CV

Arief A. Suriawinata, MD

Title(s)
Professor of Pathology and Laboratory Medicine
E. Elizabeth French Professor

Additional Titles/Positions/Affiliations
Interim Chair, Department of Pathology and Laboratory Medicine
Diplomate of the American Board of Pathology in Anatomic and Clinical Pathology, and in Clinical Informatics

Department(s)
Pathology and Laboratory Medicine

Education
Univ. Indonesia, Faculty of Medicine, MD 1995
Anatomic and Clinical Pathology Residency, The Mount Sinai Medical Center, 1996-2000
Oncologic Pathology Fellowship, Memorial Sloan-Kettering Cancer Center, 2000-2001
Gastrointestinal Oncologic Pathology Fellowship, Memorial Sloan-Kettering Cancer Center, 2001-2002

Programs
Dartmouth Cancer Center

Websites www.liverpathology.net

Contact Information

Department of Pathology and Laboratory Medicine
Dartmouth-Hitchcock Medical Center
One Medical Center Drive
Lebanon NH 03756

Office: Borwell, Level 4
Phone: 603-650-7048
Fax: 603-650-4845
Email: Arief.A.Suriawinata@hitchcock.org

Assistant: Meg Parker
Asst. Phone: 603-650-8693


Professional Interests

Gastrointestinal, Liver, Pancreas and Transplant
Surgical Pathology
Pathology and Clinical Informatics

Rotations and Thesis Projects

Gastrointestinal and Liver Pathology

Courses Taught

Gastrointestinal and Liver Pathology


Selected Publications

 

An antibody-drug conjugate designed through clone and isotype selection restricts the growth of CSPG4-expressing triple-negative breast cancer.
Esapa B, Liu Y, Chenoweth AM, Stoker K, Łabędź N, Romero-Clavijo P, Ilieva KM, Trendell J, Navarro-Llinas B, Suriawinata E, Butcher T, Wang N, Grandits M, Palhares LCGF, McCraw A, Crescioli S, Johansson A, Irshad S, Grigoriadis A, Gazinska P, Tsoka S, Chudasama V, Baker JR, Tutt ANJ, Cheung A, Thurston DE, Karagiannis SN
NPJ Precis Oncol. 2026 Mar 7; doi: 10.1038/s41698-026-01341-0. Epub 2026 Mar 7.
PMID: 41794948

Predicting targeted therapy resistance in non-small cell lung cancer using multimodal machine learning.
Hua P, Olofson A, Farhadi F, Hondelink L, Tsongalis G, Dragnev K, Hoegemann Savellano D, Suriawinata A, Tafe L, Hassanpour S
J Thorac Dis. 2025 Oct 31;17(10):8700-8714. doi: 10.21037/jtd-2025-1012. Epub 2025 Oct 29.
PMID: 41229771

An Fc-Engineered Glycomodified Antibody Supports Proinflammatory Activation of Immune Effector Cells and Restricts Progression of Breast Cancer.
Chenoweth AM, Cheung A, Chauhan J, Adams R, Osborn G, Stoker K, Grandits M, Laddach R, Trendell J, Navarro-Llinas B, Suriawinata E, Gross A, Clarke A, Brown L, Cserny J, Moise L, Jatiani S, McCraw A, Esapa B, Haider S, Quist J, Ilieva KM, Davies AM, Romero-Clavijo P, Senard T, Cheeseman J, Gardner RA, Spencer DIR, Tsoka S, Irshad S, McDonnell JM, Grigoriadis A, Tutt ANJ, Karagiannis SN
Cancer Res. 2025 Nov 14;85(22):4521-4540. doi: 10.1158/0008-5472.CAN-24-3174.
PMID: 41128663

Improving Colorectal Cancer Screening and Risk Assessment through Predictive Modeling on Medical Images and Records.
Jiang S, Robinson C, Anderson J, Hisey W, Butterly L, Suriawinata A, Hassanpour S
Am J Pathol. 2026 Feb;196(2):493-504. doi: 10.1016/j.ajpath.2025.09.016. Epub 2025 Oct 16.
PMID: 41109668

Masked pre-training of transformers for histology image analysis.
Jiang S, Hondelink L, Suriawinata AA, Hassanpour S
J Pathol Inform. 2024 Dec;15:100386. doi: 10.1016/j.jpi.2024.100386. Epub 2024 May 31.
PMID: 39006998

Oligometastatic Melanoma Treated by Metastasectomy in Combination with Immune Checkpoint and BRAF Inhibitors: A Case Series.
Palmer JP, Suriawinata AA, Yan S, Kerr DA, Afzal MZ, Shirai K
Am J Case Rep. 2023 Nov 18;24:e938537. doi: 10.12659/AJCR.938537. Epub 2023 Nov 18.
PMID: 37978795

Large-scale validation study of an improved semiautonomous urine cytology assessment tool: AutoParis-X.
Levy JJ, Chan N, Marotti JD, Kerr DA, Gutmann EJ, Glass RE, Dodge CP, Suriawinata AA, Christensen BC, Liu X, Vaickus LJ
Cancer Cytopathol. 2023 Oct;131(10):637-654. doi: 10.1002/cncy.22732. Epub 2023 Jun 28.
PMID: 37377320

Pancreatic acinar metaplasia at the gastroesophageal junction is associated with protective effect against intestinal metaplasia in patients with gastroesophageal reflux disease.
Andersen M Jr, Ren B, Romano ME, Schutz SN, Rothstein RI, Suriawinata AA, Liu X, Lisovsky M
Hum Pathol. 2023 Sep;139:1-8. doi: 10.1016/j.humpath.2023.06.009. Epub 2023 Jun 24.
PMID: 37364824

Examining longitudinal markers of bladder cancer recurrence through a semiautonomous machine learning system for quantifying specimen atypia from urine cytology.
Levy JJ, Chan N, Marotti JD, Rodrigues NJ, Ismail AAO, Kerr DA, Gutmann EJ, Glass RE, Dodge CP, Suriawinata AA, Christensen BC, Liu X, Vaickus LJ
Cancer Cytopathol. 2023 Sep;131(9):561-573. doi: 10.1002/cncy.22725. Epub 2023 Jun 26.
PMID: 37358142

MHAttnSurv: Multi-head attention for survival prediction using whole-slide pathology images.
Jiang S, Suriawinata AA, Hassanpour S
Comput Biol Med. 2023 May;158:106883. doi: 10.1016/j.compbiomed.2023.106883. Epub 2023 Apr 5.
PMID: 37031509

View more publications on PubMed